MEDEXEL
ActiveFrom the official registers: KBO 35 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of MEDEXEL is 2.8% (moderate). The 2025 annual accounts show equity of €690,641 and a net result of -€2.0m. Equity is shrinking by about 32% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 15% of 5,034 sector peers (NACE 47, financial year 2025). The company has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
4 directors, 1 in day-to-day management, last change in 2023
Board 4
Current
JONCKHEERE Vincent
Current
Director (not named in the articles) · since 23-08-2022 · in the 2025 annual accounts, filed on 29-06-2026
Current
PARISEL Alex
Current
Director (not named in the articles) · since 23-08-2022 · in the 2025 annual accounts, filed on 29-06-2026
Day-to-day management 1
Joseph Dumortier
Current
Managing director · appointed in the act of 24-06-2022
Statutory auditor 1
EY
Current
Company auditor · since 26-06-2024 · permanent representative: Marie-Laure Moreau · in the 2025 annual accounts, filed on 29-06-2026
Mandate history
8 people, 5 in office
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Jean Wallemacq |
|
| Joseph Dumortier |
|
| PARISEL Alex |
|
| JONCKHEERE Vincent |
|
| EY |
|
| Kurt Mellaerts |
|
| Bauduin Lemaire |
|
| QUEST CONSULTING |
|
How the board is organised
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Article 13. Pouvoirs de l’organe d’administration L’organe d’administration exerce tous les pouvoirs qui ne sont pas réservés expressément à…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Six ans maximum, si organe collégial et place vacante avant fin mandat, administrateurs restants ont droit coopter nouvel administrateur”“Rémunérations portées aux frais généraux indépendamment frais éventuels représentation,voyages et déplacements, mandat exercé à titre…”
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Formes prévues pour modifications aux statuts, en tout temps”
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Un ou plusieurs, pouvoirs et émoluments”
Articles of association, deed of 25-08-2022
Owners and capital
Owners
1 ownerChain of control
- PARTENA PROMERIS
- MEDEXEL
Owners 1
- PARTENA PROMERISparentSourceown accounts 2025100%
Capital and shareholders
Shareholders according to the deeds
Contribution
act of 17-01-2024 ↗
- PARTENA PROMERIS €7,999,776 in cash
Capital over the years
- 25-08-2022 Capital stated in the deed · 3,985 shares
Shares according to the articles of association
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Frais procédure et expertise pour moitié à charge cédant et pour moitié à charge acquéreurs proportionnellement nombre actions acquises…”
- Share issue ruleHow and by whom new shares can be issued.
- “Apport en numéraire avec émission nouvelles actions, organe qui procède à émission”
deed of 25-08-2022 (in French)